{"entity":{"type":"insider","cik":"0001484986","url":"/insider/0001484986","json_url":"/insider/0001484986.json","name":"Rummelt Andreas","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":6,"first":"2010-05-12","last":"2014-08-27","span_basis":"filed_date"},"name_variants":[{"name":"Rummelt Andreas","source":"filing","n_filings":6,"first_seen":"2010-05-12","last_seen":"2014-08-27"}],"transactions":[{"id":6952182,"accession":"0000899866-14-000188","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899866-14-000188","line_url":"/filing/0000899866-14-000188#line-3","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001484986","owner_name":"Rummelt Andreas","owner_display_name":"Rummelt Andreas","owner_url":"/insider/0001484986","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5052.0,"shares_display":"5,052","price_per_share":170.53,"price_display":"170.53","price_state":"stated","total_value":861517.56,"total_display":"861,517.56","total_whole":"861,518","shares_owned_after":12786.0,"shares_owned_after_display":"12,786","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-25","filed_date":"2014-08-27","scope":"insider"},{"id":3546540,"accession":"0001231977-12-000061","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001231977-12-000061","line_url":"/filing/0001231977-12-000061#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001484986","owner_name":"Rummelt Andreas","owner_display_name":"Rummelt Andreas","owner_url":"/insider/0001484986","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":107.0,"price_display":"107.00","price_state":"stated","total_value":1070000.0,"total_display":"1,070,000.00","total_whole":"1,070,000","shares_owned_after":10315.0,"shares_owned_after_display":"10,315","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-27","filed_date":"2012-07-31","scope":"insider"},{"id":2303565,"accession":"0001231977-12-000056","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001231977-12-000056","line_url":"/filing/0001231977-12-000056#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001484986","owner_name":"Rummelt Andreas","owner_display_name":"Rummelt Andreas","owner_url":"/insider/0001484986","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":91.29,"price_display":"91.29","price_state":"stated","total_value":912900.0,"total_display":"912,900.00","total_whole":"912,900","shares_owned_after":20315.0,"shares_owned_after_display":"20,315","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-06-07","filed_date":"2012-06-08","scope":"insider"},{"id":2582664,"accession":"0001231977-12-000032","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001231977-12-000032","line_url":"/filing/0001231977-12-000032#line-4","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001484986","owner_name":"Rummelt Andreas","owner_display_name":"Rummelt Andreas","owner_url":"/insider/0001484986","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3657.0,"shares_display":"3,657","price_per_share":84.96,"price_display":"84.96","price_state":"stated","total_value":310698.72,"total_display":"310,698.72","total_whole":"310,699","shares_owned_after":30315.0,"shares_owned_after_display":"30,315","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-23","filed_date":"2012-02-23","scope":"insider"},{"id":2582654,"accession":"0001231977-12-000032","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001231977-12-000032","line_url":"/filing/0001231977-12-000032#line-2","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001484986","owner_name":"Rummelt Andreas","owner_display_name":"Rummelt Andreas","owner_url":"/insider/0001484986","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2786.0,"shares_display":"2,786","price_per_share":81.27,"price_display":"81.27","price_state":"stated","total_value":226418.22,"total_display":"226,418.22","total_whole":"226,418","shares_owned_after":30315.0,"shares_owned_after_display":"30,315","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-21","filed_date":"2012-02-23","scope":"insider"},{"id":9134829,"accession":"0001231977-11-000076","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001231977-11-000076","line_url":"/filing/0001231977-11-000076#line-4","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001484986","owner_name":"Rummelt Andreas","owner_display_name":"Rummelt Andreas","owner_url":"/insider/0001484986","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9015.0,"shares_display":"9,015","price_per_share":69.01,"price_display":"69.01","price_state":"stated","total_value":622125.15,"total_display":"622,125.15","total_whole":"622,125","shares_owned_after":27200.0,"shares_owned_after_display":"27,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-10-24","filed_date":"2011-10-25","scope":"insider"},{"id":7448047,"accession":"0001231977-10-000038","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001231977-10-000038","line_url":"/filing/0001231977-10-000038#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001484986","owner_name":"Rummelt Andreas","owner_display_name":"Rummelt Andreas","owner_url":"/insider/0001484986","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":52.6,"price_display":"52.60","price_state":"stated","total_value":263000.0,"total_display":"263,000.00","total_whole":"263,000","shares_owned_after":8892.0,"shares_owned_after_display":"8,892","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-05-10","filed_date":"2010-05-12","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000899866","name":"ALEXION PHARMACEUTICALS INC","url":"/issuer/0000899866","role":"Director","n_filings":6,"first_seen":"2010-05-12","last_seen":"2014-08-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001484986","retrieved_at":"2026-08-22T19:37:15+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}